Family Medicine · Riverside, CA
NPI
1629118468
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
5750 Division St Ste 208
Riverside, CA, 92506
Phone (714) 783-6330
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
2,291 services
Medicare patients, 2024
179
Average age 72
Drug cost, 2024
$1.5M
4,012 prescriptions
Company payments, 2024
$21.81
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sachchida N Sinha was code 95004 (test - miscellaneous), 1,414 times for 18 patients. In total Sachchida N Sinha billed 2,291 services in 31 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,414 | 18 | $3.25 | $4,601 |
| 99214 Office E&M - Established | Office | 237 | 54 | $104.46 | $25K |
| 99213 Office E&M - Established | Office | 130 | 110 | $78.00 | $10K |
| 36415 Venipuncture Blood Collection | Office | 70 | 70 | $8.65 | $606 |
| 99204 Office E&M - New | Office | 61 | 61 | $138.66 | $8,458 |
| 93000 Electrocardiogram | Office | 38 | 38 | $12.46 | $473 |
| 96116 Behavioral Health Services | Office | 38 | 38 | $77.57 | $2,948 |
| 99203 Office E&M - New | Office | 36 | 36 | $95.94 | $3,454 |
| 93923 Duplex Scan - Extremity Arteries | Office | 25 | 21 | $112.78 | $2,820 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 22 | 21 | $168.28 | $3,702 |
| 93970 Duplex Scan - Extremity Veins | Office | 19 | 19 | $142.89 | $2,715 |
| 93925 Duplex Scan - Extremity Arteries | Office | 19 | 19 | $218.44 | $4,150 |
| 99212 Office E&M - Established | Office | 18 | 18 | $49.41 | $889 |
| 93040 Electrocardiogram | Office | 17 | 16 | $11.30 | $192 |
| 94060 Pulmonary Function Testing | Office | 17 | 16 | $35.32 | $600 |
By year: 2022 $16K for 341 services; 2023 $15K for 200 services; 2024 $86K for 2,291 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 70 | 70 | $8.65 | $606 |
Medicare prescription drug claims, 2024
In 2024, the drug Sachchida N Sinha prescribed most often to Medicare patients was Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate), with 244 prescriptions and refills. In total Sachchida N Sinha wrote 4,012 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 244 | 244 | 85 | $243K |
| Atorvastatin Calcium Generic | 160 | 206 | 60 | $478 |
| Tolmetin Sodium Generic | 152 | 152 | 51 | $273K |
| Amlodipine Besylate Generic | 141 | 173 | 52 | $153 |
| Gabapentin Generic | 127 | 137 | 45 | $223 |
| Meclizine Hcl Generic | 119 | 119 | 37 | $215 |
| Diflorasone Diacetate Generic | 108 | 108 | 33 | $66K |
| Zileuton Er Zileuton | 105 | 105 | 31 | $294K |
| Rosuvastatin Calcium Generic | 103 | 103 | 41 | $201 |
| Losartan Potassium Generic | 87 | 115 | 33 | $155 |
| Metformin Er Gastric Metformin Hcl | 79 | 79 | 26 | $88K |
| Fenofibrate Generic | 69 | 69 | 20 | $46K |
| Levothyroxine Sodium Generic | 69 | 96 | 27 | $782 |
| Dihydroergotamine Mesylate Generic | 65 | 65 | 20 | $60K |
| Metoprolol Succinate Generic | 60 | 64 | 19 | $178 |
Brand drugs: 624 claims; generic drugs: 3,364 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Sachchida N Sinha $21.81 ($21.81 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $21.81.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $21.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.